오피코헬스 (OPK) 주가

오피코헬스(OPK)는 NASDAQ에 상장된 Healthcare · Diagnostics & Research 기업입니다. 현재가 $1.64 (+1.23%), 시가총액 $0.97B, 52주 최저~최고 $1.10 ~ $1.58.

OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecific immune modulator to rebuild and sustain the patient's own immune system. This segment also engages in the development of Epstein Barr Virus vaccine; Rayaldee, a patented extended-release product for oral administration

핵심 지표

• 현재가: $1.64 (+1.23%)
• 시가총액: $0.97B
• 52주 최저~최고: $1.10 ~ $1.58
• 섹터: Healthcare
• 산업: Diagnostics & Research
• 거래소: NASDAQ

오피코헬스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

오피코헬스 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.1429

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 0.80
• 순이익률: -0.37%
• 영업이익률: -0.41%

자주 묻는 질문